Literature DB >> 19850875

Spatiotemporally separable Shh domains in the midbrain define distinct dopaminergic progenitor pools.

Milan Joksimovic1, Angela Anderegg, Anil Roy, Laura Campochiaro, Beth Yun, Raja Kittappa, Ronald McKay, Rajeshwar Awatramani.   

Abstract

Midbrain dopamine neurons (mDA) are important regulators of diverse physiological functions, including movement, attention, and reward behaviors. Accordingly, aberrant function of dopamine neurons underlies a wide spectrum of disorders, such as Parkinson's disease (PD), dystonia, and schizophrenia. The distinct functions of the dopamine system are carried out by neuroanatomically discrete subgroups of dopamine neurons, which differ in gene expression, axonal projections, and susceptibility in PD. The developmental underpinnings of this heterogeneity are undefined. We have recently shown that in the embryonic CNS, mDA originate from the midbrain floor plate, a ventral midline structure that is operationally defined by the expression of the molecule Shh. Here, we develop these findings to reveal that in the embryonic midbrain, the spatiotemporally dynamic Shh domain defines multiple progenitor pools. We deduce 3 distinct progenitor pools, medial, intermediate, and lateral, which contribute to different mDA clusters. The earliest progenitors to express Shh, here referred to as the medial pool, contributes neurons to the rostral linear nucleus and mDA of the ventral tegmental area/interfascicular regions, but remarkably, little to the substantia nigra pars compacta. The intermediate Shh+ progenitors give rise to neurons of all dopaminergic nuclei, including the SNpc. The last and lateral pool of Shh+ progenitors generates a cohort that populates the red nucleus, Edinger Westphal nucleus, and supraoculomotor nucleus and cap. Subsequently, these lateral Shh+ progenitors produce mDA. This refined ontogenetic definition will expand understanding of dopamine neuron biology and selective susceptibility, and will impact stem cell-derived therapies and models for PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850875      PMCID: PMC2776440          DOI: 10.1073/pnas.0904285106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice.

Authors:  A Wallén; R H Zetterström; L Solomin; M Arvidsson; L Olson; T Perlmann
Journal:  Exp Cell Res       Date:  1999-12-15       Impact factor: 3.905

2.  A role for midbrain arcs in nucleogenesis.

Authors:  Seema Agarwala; Clifton W Ragsdale
Journal:  Development       Date:  2002-12       Impact factor: 6.868

3.  Coordinated temporal and spatial control of motor neuron and serotonergic neuron generation from a common pool of CNS progenitors.

Authors:  Alexandre Pattyn; Anna Vallstedt; José M Dias; Omar Abdel Samad; Robb Krumlauf; Filippo M Rijli; Jean-Francois Brunet; Johan Ericson
Journal:  Genes Dev       Date:  2003-03-15       Impact factor: 11.361

4.  Redefining the serotonergic system by genetic lineage.

Authors:  Patricia Jensen; Anna F Farago; Rajeshwar B Awatramani; Michael M Scott; Evan S Deneris; Susan M Dymecki
Journal:  Nat Neurosci       Date:  2008-03-16       Impact factor: 24.884

5.  Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells.

Authors:  Stina Friling; Elisabet Andersson; Lachlan H Thompson; Marie E Jönsson; Josephine B Hebsgaard; Evanthia Nanou; Zhanna Alekseenko; Ulrika Marklund; Susanna Kjellander; Nikolaos Volakakis; Outi Hovatta; Abdeljabbar El Manira; Anders Björklund; Thomas Perlmann; Johan Ericson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

6.  A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b.

Authors:  M P Smidt; C H Asbreuk; J J Cox; H Chen; R L Johnson; J P Burbach
Journal:  Nat Neurosci       Date:  2000-04       Impact factor: 24.884

7.  Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.

Authors:  Jong-Hoon Kim; Jonathan M Auerbach; José A Rodríguez-Gómez; Iván Velasco; Denise Gavin; Nadya Lumelsky; Sang-Hun Lee; John Nguyen; Rosario Sánchez-Pernaute; Krys Bankiewicz; Ron McKay
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

8.  Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice.

Authors:  Dong-Youn Hwang; Paul Ardayfio; Un Jung Kang; Elena V Semina; Kwang-Soo Kim
Journal:  Brain Res Mol Brain Res       Date:  2003-06-10

9.  Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis.

Authors:  Marie E Jönsson; Yuichi Ono; Anders Björklund; Lachlan H Thompson
Journal:  Exp Neurol       Date:  2009-06-23       Impact factor: 5.330

10.  Otx dose-dependent integrated control of antero-posterior and dorso-ventral patterning of midbrain.

Authors:  Eduardo Puelles; Dario Acampora; Emmanuel Lacroix; Massimo Signore; Alessandro Annino; Francesca Tuorto; Stefania Filosa; Giorgio Corte; Wolfgang Wurst; Siew-Lan Ang; Antonio Simeone
Journal:  Nat Neurosci       Date:  2003-05       Impact factor: 24.884

View more
  55 in total

1.  Organotypic slice cultures of embryonic ventral midbrain: a system to study dopaminergic neuronal development in vitro.

Authors:  Gabriela Oana Bodea; Sandra Blaess
Journal:  J Vis Exp       Date:  2012-01-31       Impact factor: 1.355

2.  Molecular organization and timing of Wnt1 expression define cohorts of midbrain dopamine neuron progenitors in vivo.

Authors:  Ashly Brown; Jason T Machan; Lindsay Hayes; Mark Zervas
Journal:  J Comp Neurol       Date:  2011-10-15       Impact factor: 3.215

3.  Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling.

Authors:  Jean-Francois Poulin; Jian Zou; Janelle Drouin-Ouellet; Kwang-Youn A Kim; Francesca Cicchetti; Rajeshwar B Awatramani
Journal:  Cell Rep       Date:  2014-10-30       Impact factor: 9.423

4.  Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons.

Authors:  Ahmad Salti; Roxana Nat; Sonya Neto; Zoe Puschban; Gregor Wenning; Georg Dechant
Journal:  Stem Cells Dev       Date:  2012-09-20       Impact factor: 3.272

5.  Leptin signaling modulates the activity of urocortin 1 neurons in the mouse nonpreganglionic Edinger-Westphal nucleus.

Authors:  Lu Xu; Wim J J M Scheenen; Rebecca L Leshan; Christa M Patterson; Carol F Elias; Sanne Bouwhuis; Eric Willem Roubos; Martin G Myers; Tamás Kozicz
Journal:  Endocrinology       Date:  2011-01-05       Impact factor: 4.736

Review 6.  Classification of Midbrain Dopamine Neurons Using Single-Cell Gene Expression Profiling Approaches.

Authors:  Jean-Francois Poulin; Zachary Gaertner; Oscar Andrés Moreno-Ramos; Rajeshwar Awatramani
Journal:  Trends Neurosci       Date:  2020-02-11       Impact factor: 13.837

7.  Nato3 integrates with the Shh-Foxa2 transcriptional network regulating the differentiation of midbrain dopaminergic neurons.

Authors:  Einat Nissim-Eliraz; Sophie Zisman; Omri Schatz; Nissim Ben-Arie
Journal:  J Mol Neurosci       Date:  2012-12-21       Impact factor: 3.444

8.  Sonic hedgehog expressing and responding cells generate neuronal diversity in the medial amygdala.

Authors:  Rosalind S E Carney; Jean-Marie Mangin; Lindsay Hayes; Kevin Mansfield; Vitor H Sousa; Gord Fishell; Robert P Machold; Sohyun Ahn; Vittorio Gallo; Joshua G Corbin
Journal:  Neural Dev       Date:  2010-05-27       Impact factor: 3.842

9.  Dynamic temporal requirement of Wnt1 in midbrain dopamine neuron development.

Authors:  Jasmine Yang; Ashly Brown; Debra Ellisor; Erin Paul; Nellwyn Hagan; Mark Zervas
Journal:  Development       Date:  2013-03       Impact factor: 6.868

10.  Cell intrinsic and extrinsic factors contribute to enhance neural circuit reconstruction following transplantation in Parkinsonian mice.

Authors:  Jessica Kauhausen; Lachlan H Thompson; Clare L Parish
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.